Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceuticals ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 16:15 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- PLN 20.46T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | PLN 18.7B | PLN 53.23 | 4.82% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | PLN 36.4B | PLN 383.28 | 1.47% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | PLN 26.4B | PLN 388.76 | 0.24% up | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | PLN 21.1B | PLN 501.14 | 0.94% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | PLN 15.7B | PLN 114.69 | 3.05% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | PLN 30.4B | PLN 386.95 | 1.04% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | PLN 19.6B | PLN 347.81 | 0.69% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | PLN 39.3B | PLN 259.89 | 2.93% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | PLN 95.3B | PLN 83.17 | 1.00% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | PLN 113.1B | PLN 156.03 | 0.10% up | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | PLN 18B | PLN 164.44 | 2.85% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | PLN 30.2B | PLN 86.69 | 1.94% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | PLN 158.5B | PLN 275.57 | 0.35% down | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | PLN 198.5B | PLN 170.12 | 0.87% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | PLN 127.4B | PLN 206.64 | 1.23% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | PLN 34.3B | PLN 1,226.83 | 0.12% down | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | PLN 31.5B | PLN 187.68 | 2.55% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | PLN 274.8B | PLN 86.01 | 1.29% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | PLN 1.38T | PLN 561.64 | 2.71% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | PLN 32.7B | PLN 501.50 | 0.10% down | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | PLN 19.4B | PLN 202.37 | 1.64% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | PLN 24.1B | PLN 1,205.45 | 1.90% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | PLN 2.67T | PLN 1,107.81 | 1.28% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | PLN 62.9B | PLN 980.55 | 1.17% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | PLN 397.5B | PLN 3,842.65 | 0.36% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | PLN 4.98T | PLN 5,589.08 | 1.94% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | PLN 493.5B | PLN 241.43 | 2.27% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | PLN 26B | PLN 640.86 | 0.91% up | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | PLN 23.9B | PLN 366.73 | 0.95% down | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | PLN 71.2B | PLN 1,086.14 | 0.53% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | PLN 544.7B | PLN 2,148.42 | 0.12% down | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | PLN 2.05T | PLN 1,160.48 | 1.57% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | PLN 1.19T | PLN 628.62 | 1.89% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | PLN 98.6B | PLN 2,314.43 | 1.59% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | PLN 53.1B | PLN 106.16 | 1.99% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | PLN 60.9B | PLN 312.42 | 1.03% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | PLN 185.7B | PLN 1,625.86 | 2.29% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | PLN 646.1B | PLN 113.35 | 1.12% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | PLN 32.6B | PLN 469.89 | 0.08% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | PLN 46.7B | PLN 241.15 | 2.36% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | PLN 24.6B | PLN 174.35 | 0.72% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | PLN 393.5B | PLN 196.33 | 0.97% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | PLN 50.3B | PLN 60.28 | 1.23% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | PLN 1.12T | PLN 719.52 | 1.96% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | PLN 23.4B | PLN 34.37 | 1.10% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | PLN 457.3B | PLN 190.43 | 0.49% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | PLN 28.3B | PLN 537.34 | 1.84% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | PLN 30.1B | PLN 274.85 | 2.58% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | PLN 703.9B | PLN 159.72 | 2.54% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | PLN 726.4B | PLN 419.44 | 0.52% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | PLN 20.3B | PLN 242.88 | 0.07% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | PLN 28.7B | PLN 206.00 | 0.95% down | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | PLN 19.9B | PLN 114.37 | 1.99% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | PLN 38.3B | PLN 1,650.02 | 2.89% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | PLN 29.5B | PLN 336.78 | 1.88% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | PLN 137B | PLN 337.20 | 0.32% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | PLN 34.5B | PLN 43.10 | 0.33% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | PLN 106B | PLN 483.20 | 1.52% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | PLN 12.7B | PLN 65.39 | 0.81% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | PLN 18.3B | PLN 110.02 | 1.35% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | PLN 82.5B | PLN 615.61 | 2.31% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0265 PLN).
Questions and answers
Which pharmaceuticals rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceuticals ranked by one-year price change as of 18 Nov 2026, 16:15 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of PLN 20.46T as of 18 Nov 2026, 16:15 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.